Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Laboratory Services

 

Cerba expands

Cerba HealthCare, the big French international diagnostic lab group, is expanding rapidly in Italy and looking at other markets.

FREE BLOG The secret of Israeli healthcare

It is ironic that conferences on best practice in healthcare are dominated by Americans – the people who have the world’s most dysfunctional healthcare system. Israel and Taiwan are much better bets. So how do they do it?

French lab group set to sell for 3-3.6 times revenue

We hear that a large deal is about to go down in the French diagnostic laboratory sector and will see a price of 3-3.6x revenue paid. A source says there is a bidding war between two of the country's four largest groups.

Mid Europa enters the Serbian private healthcare market

Private equity investor Mid Europa has entered the Serbian private healthcare market for the first time, with the acquisition of hospital operator MediGroup. We speak to a partner at seller Blue Sea Capital.

Interview: Philips Indonesia CEO on how the private sector is benefiting from UHC

In 2014 the Indonesian government pledged to introduce universal health coverage to the world's fourth most populous country.  Healthcare Nova speaks to the CEO of healthcare focused tech company Indonesia Philips, Suryo Suwignjo, about how healthcare companies can see opportunity where others see impossibility, and how UHC is facilitating the growth of the private market.

Medicover moves into wellness, but reports losses in the UK

Pan- European and Indian healthcare and diagnostics provider Medicover is entering the wellness market, in a move that could provide interesting synergies with its corporate healthcare offering, mainly in Poland and Romania. The company's H1 and second quarter financials show losses in the Indian and UK fertility markets, but strong growth in Eastern Europe. We […]

Could buyers be interested in Fortis’ struggling diagnostics arm SRL?

After Malaysian healthcare giant IHH's $1.3bn buy-out of controversy-riddled Fortis Healthcare, the Indian hospital group's diagnostic lab SRL has launched a major push to improve its dwindling sales. Is it worth trying to impress incoming management, or will Fortis drop the business? We speak to an analyst to find out more.

Find Us